Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes research and clinical practice"
DOI: 10.1016/j.diabres.2018.02.025
Abstract: AIMS Sarcopenia has recently been shown to affect quality of life and mortality in patients with diabetes. However, early detection requires an expensive equipment. We hypothesized that the ratio of the creatinine/cystatin (Cre/CysC) could be… read more here.
Keywords: sarcopenia; patients type; ratio; type diabetes ... See more keywords
The Systemic Immune Inflammation Index (SII) Combined with the Creatinine-to-Cystatin C Ratio (Cre/CysC) Predicts Sarcopenia in Patients with Liver Cirrhosis Complicated with Primary Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2023 at "Nutrition and Cancer"
DOI: 10.1080/01635581.2023.2176199
Abstract: Abstract Background Sarcopenia is a risk factor for poor cancer prognosis. Early identification and timely intervention of sarcopenia can improve patient prognosis. Methods A total of 91 patients with liver cirrhosis complicated with primary hepatocellular… read more here.
Keywords: hepatocellular carcinoma; complicated primary; primary hepatocellular; cre cysc ... See more keywords